A useful market-entry brief does not try to describe everything. It reduces uncertainty around a specific commitment and makes the next decision easier to defend.
By Alexey Kosov
Founder, KosovTeam Consulting
Evidence checked: Oct 5, 2026
Method note: AI-assisted research and drafting may be used to expand source coverage and structure analysis. The decision logic, claim boundaries and public release remain human-gated.
Before a team commits to a market, segment or launch path, the brief should make four things visible:
- what the evidence supports;
- how that evidence is interpreted;
- what changes in the decision;
- what remains unknown.
That discipline matters more than page count.
Start with the decision, not “the market”
“Research the market” is not a decision question.
A better starting point is one of these:
- enter now or not yet;
- choose between two segments;
- test one route to market;
- decide whether deeper diligence is justified;
- identify which assumption must be validated before launch.
The decision boundary determines what evidence matters.
If the immediate question is whether a market deserves deeper work, the brief may need market structure, barriers, buyer or partner routes, competitive conditions and critical unknowns.
It does not automatically need every competitor, a complete account universe or a full market-size model.
Freeze the scope and universe
Country, segment, product, buyer, use case and selection rule should not remain implicit.
State:
- what is inside the scope;
- what is outside it;
- how competitors, partners or target organisations were selected;
- what the list can and cannot prove.
A list of real companies is not evidence of fit.
If product configuration, integration model or buyer role is still unresolved, call the list what it is: a research universe for qualification, not a validated lead list.
Set an evidence policy
The brief should make the source hierarchy visible.
Primary and authoritative sources should support material facts where they exist. Secondary sources can add context. Discovery sources can help find a lead, but they should not silently become evidence for a material claim.
The source policy should also say what a source cannot prove.
An official statistic can describe sector scale or direction.
A company website can show public positioning or a contact route.
An event exhibitor list can provide a sampling frame.
None of those proves buyer intent, product-market fit or commercial probability on its own.
Keep the evidence chain visible
A reviewable brief separates:
SOURCE
Where the evidence comes from.
OBSERVED
What the source directly supports.
INTERPRETATION
What the evidence may mean for the current decision.
IMPLICATION
What changes in an option, risk or next step.
UNKNOWN
What remains unresolved.
This is not formatting for its own sake.
It lets a reader challenge an interpretation without losing the evidence underneath it.
Turn evidence into options and trade-offs
Facts are not the final deliverable.
A decision brief should expose the choice set created by the evidence:
- focused validation versus broad launch;
- direct sales versus a partner route;
- one segment versus another;
- immediate action versus a deliberate wait.
The purpose is not to manufacture a recommendation.
It is to make assumptions, trade-offs, invalidators and missing evidence visible enough that the recommendation can be challenged.
Make the next checks explicit
A strong brief reduces the next research problem as well as the current uncertainty.
It should identify:
- which unknowns are material enough to test next;
- which can remain unresolved for now;
- what new evidence would change the decision.
That may mean testing one or two buyer use cases, verifying a technical dependency, confirming the real buying unit, obtaining comparable quotations only after the configuration is defined, or checking a regulatory requirement against the specific product rather than the industry in general.
A bounded example: Germany industrial automation
In a KTC self-client dry run, we tested whether a compact public-source pack could support an early market-entry screen for an industrial-automation supplier in Germany.
The evidence set combined:
- VDMA sector material;
- Germany Trade & Invest installed-base and industry context;
- relevant EU regulatory sources;
- public competitor material;
- public corporate routes.
The working output included a market overview, entry and regulatory considerations, competitor snapshots, a first-stage organisation universe, a source register and explicit limitations.
The important part was not the volume.
The decision logic was:
SOURCE
VDMA, Germany Trade & Invest, EU regulatory sources and public company material.
OBSERVED
Germany has a substantial industrial-automation base, established suppliers and an evolving regulatory context.
INTERPRETATION
A generic “robotics supplier” proposition would be too weak. Integration, use-case economics and route to market matter.
IMPLICATION
Validate one or two specific use cases and the partner/integration path before treating a broad launch as justified.
UNKNOWN
The dry run did not know the real supplier’s exact product configuration, scale, buying unit or deal economics.
That UNKNOWN changes how the target list must be read.
The organisations are a research universe demonstrating the delivery format, not qualified leads.
This is self-client evidence. It does not prove paid-client acceptance, ROI, conversion or market-entry success.
What this changes for a management team
Before committing, a bounded decision brief should answer seven questions:
1. What decision are we making?
2. What scope and universe are we actually studying?
3. Which sources support the material facts?
4. What is observed, and what is interpreted?
5. Which options and trade-offs follow?
6. Which next checks could change the decision?
7. What remains unknown?
If those seven elements are clear, the brief can be short and still be useful.
If they are not clear, more pages usually add volume rather than confidence.
Limits
Public-source research can structure uncertainty.
It cannot replace direct buyer validation, legal advice, product-specific regulatory assessment, technical integration work or commercial testing.
A representative sample is not a census.
A public contact route is not buying intent.
A competitor page is not a complete view of commercial reality.
Those boundaries belong in the body of the brief, not in a disclaimer added after the recommendation.
Sources
Germany Trade & Invest — Robotics Industry in Germany
EUR-Lex — EU Data Act, Regulation (EU) 2023/2854
European Commission — Cyber Resilience Act reporting obligations
Leave a Reply